形聚合物微粒球形核酸 (SNA) 作为药物输送车辆
John P Cavaliere1,2, Connor M Forsyth3,2, Allen X Guo4,2
1Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States.
Bioconjugate chemistry
|December 19, 2025
概括
研究人员开发了新型的两性聚合物微粒球形核酸 (APM-SNAs),用于增强疏水性药物输送. 这些APM-SNAs通过调整核心水性和寡核酸密度,显示出更好的细胞吸收,药物封装和治疗疗效.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 球形核酸 (SNA) 为生物医学应用提供了独特的特性.
- 两性聚合物微粒 (APM) 是对疏水药物的有希望的纳米载体.
- 开发高效的输送系统,用于疏水治疗药物仍然是一个挑战.
研究的目的:
- 合成和表征一种新的类型的APM衍生SNAs (APM-SNAs) 用于疏水性药物输送.
- 研究APM-SNA结构,包括核心疏水性和寡核酸密度,对细胞吸收,药物负载和治疗疗效的影响.
- 为了评估APM-SNAs在提供特定的STAT3抑制剂方面的性能,WP1066.6.
主要方法:
- 合成带有不同疏水性块 (例如,甲基酸盐,n-丁甲基酸盐) 和一个疏水性聚乙烯糖块的两性共聚合物.
- 通过点击化学将基因改性寡核酸与化物终结的聚合物核结合,形成APM-SNA.
- APM-SNAs的表征,包括细胞吸收研究,免疫激活分析,药物封装效率和体外药物释放动力学.
- 在Caki-1细胞中使用STAT3抑制剂 (WP1066) 的治疗疗效的评估.
主要成果:
- 细胞吸收APM-SNAs增加了高达10倍,与较高的寡核酸密度.
- 增加核心疏水性 (甲酸) 的APM-SNA显示细胞吸收增强,改善WP1066封装 (67%vs41%) 和释放概况 (半衰期27.8vs7.4小时).
- 寡核酸序列影响了细胞吸收,T20-SNAs显示比CpG和G-四重复序列的吸收量大约40%.
- 通过T20基APM-SNAs输送的WP1066显示出功效提高了40%,使EC50从6.18降低到3.54μM.
结论:
- APM-SNAs代表了一种用于疏水药物递送的多功能平台,具有可调节的结构性质.
- 增加APM-SNA核心的疏水性和优化药物核心相互作用显著增强药物封装,延长释放,并改善治疗结果.
- 这些发现凸显了APM-SNAs在开发更有效的纳米药物以挑战疏水性药物的潜力.
相关概念视频
Micelles
269
Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
269
Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127


